Showing 15,901 - 15,920 results of 120,802 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 1.08s Refine Results
  1. 15901
  2. 15902
  3. 15903
  4. 15904

    AprA, CfaD, and QkgA are required for inhibition of proliferation by BzpN. by Jonathan E. Phillips (214646)

    Published 2011
    “…Values are mean ± SEM, n≥3. Expression of BzpN-GFP in wild-type cells resulted in a significant decrease in cell density on days 5 through 8 with p<0.05, whereas expression of BzpN-GFP in <i>aprA<sup>−</sup>, cfaD<sup>−</sup>, or qkgA<sup>−</sup></i> cells did not cause a significant reduction in cell density at any measured timepoint (t-test). …”
  5. 15905
  6. 15906
  7. 15907
  8. 15908
  9. 15909
  10. 15910
  11. 15911
  12. 15912
  13. 15913
  14. 15914

    Divergent effects of DYRK1A KD in HBV-infected PHH. by Florentin Pastor (19852287)

    Published 2024
    “…(B) Representative Western blot analysis of DYRK1A KD levels. (C) and (D) DYRK1A and HBV RNA analysis of a set of 3 independent experiments, each performed in triplicate, in which a decrease of HBV RNAs was observed. …”
  15. 15915
  16. 15916
  17. 15917
  18. 15918
  19. 15919

    M<sup>6</sup>A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling by Jian-Qing Chen (8271900)

    Published 2022
    “…Through rescue experiments, we were able to confirm that the unfavorable impact of LIFR-AS1 knockdown on VEGFA /PI3K/Akt Signaling could be reversed via the inhibition of miR-150-5p expression. Together, these findings indicate that a noval m6A-LIFR-AS1 axis promotes PC progression at least in part via regulation of the miR-150-5p/VEGFA axis, indicating that this regulatory axis may be a viable clinical target for the treatment of PC.…”
  20. 15920